• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: BIOMARKERS IN MS

MS biomarkers – the year in review

December 16, 2025  

ECTRIMS 2025 HIGHLIGHTS – SATURDAY, SEPTEMBER 27, 2025

September 27, 2025  

ECTRIMS 2025 HIGHLIGHTS – FRIDAY, SEPTEMBER 26, 2025

September 26, 2025  

ECTRIMS 2025 HIGHLIGHTS – THURSDAY, SEPTEMBER 25, 2025

September 25, 2025  

Baseline sNfL prognostic of disease activity in CIS

August 21, 2025  

EAN HIGHLIGHTS – TUESDAY, JUNE 24, 2025

June 24, 2025  

EAN HIGHLIGHTS – MONDAY, JUNE 23, 2025

June 23, 2025  

AAN 2025 – report on fluid biomarkers in MS

April 22, 2025  

AAN DAILY HIGHLIGHTS – WEDNESDAY, APRIL 9, 2025

April 9, 2025  

AAN DAILY HIGHLIGHTS – TUESDAY, APRIL 8, 2025

April 8, 2025  
1
2
3
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Ultomiris (ravulizumab) now publicly reimbursed in gMG posted on April 7, 2026
  • Ofatumumab – new data on efficacy and safety posted on April 14, 2025
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions